![Successful establishment of the mouse NASH model. (A) Representative... | Download Scientific Diagram Successful establishment of the mouse NASH model. (A) Representative... | Download Scientific Diagram](https://www.researchgate.net/publication/348790596/figure/fig2/AS:990785960935438@1613233189941/Successful-establishment-of-the-mouse-NASH-model-A-Representative-images-of-liver.png)
Successful establishment of the mouse NASH model. (A) Representative... | Download Scientific Diagram
![One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2021/05/c1008e24bbb678110a0cb988df414a97/preprints-42692-graphical.v2%20111.png)
One Week Feeding of CDAHFD Induces Steatohepatitis and Mitochondrial Dysfunction with Oxidative Stress in Liver[v1] | Preprints.org
![PDF] Solithromycin Diminishes Steatohepatitis by Modulating Gluconeogenesis and Inhibits Tumor Growth in a Diabetic Mouse Model of Non-Alcoholic Steatohepatitis | Semantic Scholar PDF] Solithromycin Diminishes Steatohepatitis by Modulating Gluconeogenesis and Inhibits Tumor Growth in a Diabetic Mouse Model of Non-Alcoholic Steatohepatitis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/be4a3615209a61c7301072e214d2a55efc35365a/2-Figure1-1.png)
PDF] Solithromycin Diminishes Steatohepatitis by Modulating Gluconeogenesis and Inhibits Tumor Growth in a Diabetic Mouse Model of Non-Alcoholic Steatohepatitis | Semantic Scholar
![Mouse models of nonalcoholic steatohepatitis and their application to new drug development | Archives of Pharmacal Research Mouse models of nonalcoholic steatohepatitis and their application to new drug development | Archives of Pharmacal Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12272-022-01410-5/MediaObjects/12272_2022_1410_Fig1_HTML.png)
Mouse models of nonalcoholic steatohepatitis and their application to new drug development | Archives of Pharmacal Research
![NASH (Non-alcoholic Steatohepatitis) mouse model_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._NASH,Non-alcoholic,Steatohepatitis,mouse,model NASH (Non-alcoholic Steatohepatitis) mouse model_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._NASH,Non-alcoholic,Steatohepatitis,mouse,model](https://www.biocytogen.jp/Uploads/Picture/2021/07/15/u60f0587f1e5d9.png)
NASH (Non-alcoholic Steatohepatitis) mouse model_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._NASH,Non-alcoholic,Steatohepatitis,mouse,model
![Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12876-020-01356-2/MediaObjects/12876_2020_1356_Fig2_HTML.png)
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis | BMC Gastroenterology | Full Text
![Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells | Stem Cell Research & Therapy | Full Text Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13287-021-02476-6/MediaObjects/13287_2021_2476_Fig1_HTML.png)
Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells | Stem Cell Research & Therapy | Full Text
![Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better - Cellular and Molecular Gastroenterology and Hepatology Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better - Cellular and Molecular Gastroenterology and Hepatology](https://www.cmghjournal.org/cms/asset/c37a2293-b2d1-4d8a-8a44-d4d5e71d4545/gr1.jpg)
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better - Cellular and Molecular Gastroenterology and Hepatology
![Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic - Drug Discovery World (DDW) Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic - Drug Discovery World (DDW)](https://www.ddw-online.com/media/32/358-figure-2.jpg)
Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic - Drug Discovery World (DDW)
![Pathophysiological features of NASH–HCC model mice. (A) Representative... | Download Scientific Diagram Pathophysiological features of NASH–HCC model mice. (A) Representative... | Download Scientific Diagram](https://www.researchgate.net/publication/315695344/figure/fig1/AS:477437810221058@1490841452978/Pathophysiological-features-of-NASH-HCC-model-mice-A-Representative-macroscopic.png)
Pathophysiological features of NASH–HCC model mice. (A) Representative... | Download Scientific Diagram
![A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. - Abstract - Europe PMC A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6054570/bin/nihms953228u1.jpg)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. - Abstract - Europe PMC
![Advancing NASH Preclinical Research with Humanized Mouse Models for Innovative Therapeutics | TransCure bioServices Advancing NASH Preclinical Research with Humanized Mouse Models for Innovative Therapeutics | TransCure bioServices](https://transcurebioservices.com/wp-content/uploads/2023/10/nafld-spectrum.png)
Advancing NASH Preclinical Research with Humanized Mouse Models for Innovative Therapeutics | TransCure bioServices
![A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer - ScienceDirect A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827818301752-fx1.jpg)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer - ScienceDirect
![Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies | Scientific Reports Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-32037-1/MediaObjects/41598_2023_32037_Fig1_HTML.png)
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies | Scientific Reports
![JExpMed on X: ".@giobenegiamo et al. @Auwerx_Lab investigate how genetics affects non-alcoholic steatohepatitis (NASH) in mice. Only the PWK/PhJ strain develops severe hepatic #inflammation, #fibrosis and #mitochondria dysfunction and is a novel # JExpMed on X: ".@giobenegiamo et al. @Auwerx_Lab investigate how genetics affects non-alcoholic steatohepatitis (NASH) in mice. Only the PWK/PhJ strain develops severe hepatic #inflammation, #fibrosis and #mitochondria dysfunction and is a novel #](https://pbs.twimg.com/media/Fo8WbTmXwBsW_LK.jpg)